SMI DRUG DISCOVERY LIMITED Financials
- Company number
- 11175710CopyCopy
- Registered office
- Libra Building, 339 Exning Road, Newmarket, Suffolk CB8 0AT
- Incorporated
- 29/01/2018
Company snapshot
- Status
- Active
- Employees
- 14 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
16.58%vs 20242024: £1.13M
Total Assets
26.65%vs 20242024: £1.24M
Cash in Bank
23.36%vs 20242024: £668.81K
Total Liabilities
88.01%vs 20242024: £86.61K
Employees
+1vs 20242024: 13
In 2025, SMI DRUG DISCOVERY LIMITED reported net assets of £1.32M. The same filing shows total assets of £1.58M, cash in bank of £825.01K and total liabilities of £162.84K. Reported headcount was 14 in 2025. Total Assets rose from £1.24M in 2024 to £1.58M in 2025 (26.65%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
16.58%from £1.13M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures SMI DRUG DISCOVERY LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+62%vs 2023+27.3% a year compound (CAGR)
Cash in Bank
+70.4%vs 2023+30.5% a year compound (CAGR)
Total Assets
+71.9%vs 2023+31.1% a year compound (CAGR)
Total Liabilities
+103%vs 2023+42.5% a year compound (CAGR)
Employees
+16.7%vs 2023+2Biggest increase
Total Liabilities+103%
£80.19K in 2023 to £162.84K in 2025
Every indicator Okredo holds for SMI DRUG DISCOVERY LIMITED rose between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, with net assets, cash in bank, total assets and employee numbers climbing alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from SMI DRUG DISCOVERY LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 83.74%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 10.34%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 506.64%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 52.36%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for SMI DRUG DISCOVERY LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 741.67K | 1.59M | 814.51K | 1.13M | 1.32M |
| Total Assets£ | 868.27K | 1.69M | 916.44K | 1.24M | 1.58M |
| Cash in Bank£ | 695.06K | 819.19K | 484.10K | 668.81K | 825.01K |
| Total Liabilities£ | 108.87K | 72.83K | 80.19K | 86.61K | 162.84K |
| Employees | 1 | 10 | 12 | 13 | 14 |
SMI DRUG DISCOVERY LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for SMI DRUG DISCOVERY LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
SMI DRUG DISCOVERY LIMITED reported net assets of £1.32M for 2025. That compares with £1.13M in 2024, a change of 16.58%.
SMI DRUG DISCOVERY LIMITED reported total assets of £1.58M for 2025. That compares with £1.24M in 2024, a change of 26.65%.
SMI DRUG DISCOVERY LIMITED reported cash in bank of £825.01K for 2025. That compares with £668.81K in 2024, a change of 23.36%.
SMI DRUG DISCOVERY LIMITED reported 14 employees in 2025, compared with 13 in 2024.
Between 2023 and 2025, SMI DRUG DISCOVERY LIMITED's net assets rose by 62%, cash in bank rose by 70.4%, total assets rose by 71.9% and total liabilities rose by 103%. Net assets compounded at 27.3% a year across the two years to 2025, from £814.51K to £1.32M. Reported headcount went from 12 in 2023 to 14 in 2025 (+2).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.